Biotech / Pharma
BrainChild Bio
Biotech / Pharma
BrainChild Bio, a biotech startup developing treatments for childhood brain cancer, secured $116 million in Series A funding from investors including Seattle Children's Hospital and WRF Capital.
Founded
Region
Investors
People